BEST3 Trial

The BEST3 Trial is a Cluster Randomised Controlled Trial comparing the Cytosponge™-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care. The following types of the samples are collected as part of the Trial methodology: • Cytosponge™ samples • Saliva samples (TFF3-positive Cytosponge™ cases) • Endoscopic biopsy samples including gastric cardia and clinically-indicated oesophageal biopsies Cytosponge™ and endoscopic biopsy samples will be further processed into FFPE blocks and tissue sections.

Existing samples:

  • Fit and well (finding)

Contact Information

Email:
bm482@medschl.cam.ac.uk
Address:

Cambridge University Hospitals NHS Foundation Trust
Addenbrookes Hospital, Hills Rd
Cambridge
Cambridgeshire
CB2 0QQ
England

Last Updated: 04/05/2020


Annual Statistics

Year Access Requests Received Access Requests Approved
Internal External Commercial Internal External Commercial
2015 0 0 0 0 0 0
2016 0 0 0 0 0 0
2017 0 0 0 0 0 0
2018 0 0 0 0 0 0
2019 0 0 0 0 0 0
2020 0 1 1 0 1 1
2021 N/A N/A N/A N/A N/A N/A
2022 N/A N/A N/A N/A N/A N/A